Different Intravitreal Injection Techniques and Pain Level

NCT ID: NCT02497092

Last Updated: 2016-04-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

300 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine whether certain intravitreal injection techniques cause less pain than others and would therefore be beneficial for the patient's well being.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Injection Site Discomfort

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Slow angled injection

Slow and angled insertion of the needle through the sclera

Group Type ACTIVE_COMPARATOR

Technique of injection

Intervention Type OTHER

Slow straight injection

Slow and straight insertion of the needle through the sclera

Group Type ACTIVE_COMPARATOR

Technique of injection

Intervention Type OTHER

Fast angled injection

fast and angled insertion of the needle through the sclera

Group Type ACTIVE_COMPARATOR

Technique of injection

Intervention Type OTHER

Fast straight injection

fast and straight insertion of the needle through the sclera

Group Type ACTIVE_COMPARATOR

Technique of injection

Intervention Type OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Technique of injection

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients receiving intravitreal anti vascular endothelial growth factor (VEGF) injections
* Informed consent

Exclusion Criteria

* Dementia or any other reason for cognitive deterioration
* Technical limitations not allowing injecting by the protocol
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Rabin Medical Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Amir Sternfeld

MD

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Amir Sternfeld, MD

Role: PRINCIPAL_INVESTIGATOR

Rabin Medical Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Rabin Medical Center

Petah Tikva, , Israel

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Israel

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Amir Sternfeld, MD

Role: CONTACT

972-50-7665980

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Amir Sternfeld, MD

Role: primary

972-50-7665980

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

0021-15-RMC

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.